Salvesen HB - Search Results

1

Mauland KK, Wik E, Hoivik EA, Kusonmano K, Halle MK, Berg A, Haugland HK, Øyan AM, Kalland KH, Stefansson IM, Akslen LA, Krakstad C, Trovik J, Werner HM, Salvesen HB. Mauland KK, et al. Among authors: salvesen hb. Oncotarget. 2017 Feb 7;8(6):9696-9707. doi: 10.18632/oncotarget.14201. Oncotarget. 2017. PMID: 28039471 Free PMC article.

2

Clinical value of DNA content assessment in endometrial cancer.

Mauland KK, Wik E, Salvesen HB. Mauland KK, et al. Among authors: salvesen hb. Cytometry B Clin Cytom. 2014 May;86(3):154-63. doi: 10.1002/cyto.b.21164. Epub 2014 Feb 14. Cytometry B Clin Cytom. 2014. PMID: 24532190 Free article. Review.

3

Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.

Stefansson IM, Salvesen HB, Akslen LA. Stefansson IM, et al. Among authors: salvesen hb. Int J Cancer. 2006 Mar 1;118(5):1227-33. doi: 10.1002/ijc.21415. Int J Cancer. 2006. PMID: 16152605

4

Vascular proliferation is important for clinical progress of endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA. Stefansson IM, et al. Among authors: salvesen hb. Cancer Res. 2006 Mar 15;66(6):3303-9. doi: 10.1158/0008-5472.CAN-05-1163. Cancer Res. 2006. PMID: 16540684

5

GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.

Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB. Engelsen IB, et al. Among authors: salvesen hb. Am J Obstet Gynecol. 2008 Nov;199(5):543.e1-7. doi: 10.1016/j.ajog.2008.04.043. Epub 2008 Jul 3. Am J Obstet Gynecol. 2008. PMID: 18599012

6

Biologic markers in endometrial cancer treatment.

Engelsen IB, Akslen LA, Salvesen HB. Engelsen IB, et al. Among authors: salvesen hb. APMIS. 2009 Oct;117(10):693-707. doi: 10.1111/j.1600-0463.2009.02467.x. APMIS. 2009. PMID: 19775337 Review.

7

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.

Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS; MoMaTec Study Group; Vandenput I, Amant F, Akslen LA, Salvesen HB. Trovik J, et al. Among authors: salvesen hb. Clin Cancer Res. 2011 May 15;17(10):3368-77. doi: 10.1158/1078-0432.CCR-10-2412. Epub 2011 Jan 17. Clin Cancer Res. 2011. PMID: 21242118 Free article.

8

Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.

Mannelqvist M, Stefansson IM, Bredholt G, Hellem Bø T, Oyan AM, Jonassen I, Kalland KH, Salvesen HB, Akslen LA. Mannelqvist M, et al. Among authors: salvesen hb. Am J Pathol. 2011 Feb;178(2):861-71. doi: 10.1016/j.ajpath.2010.10.040. Am J Pathol. 2011. PMID: 21281818 Free PMC article.

9

Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective.

Trovik J, Mauland KK, Werner HM, Wik E, Helland H, Salvesen HB. Trovik J, et al. Among authors: salvesen hb. Gynecol Oncol. 2012 May;125(2):381-7. doi: 10.1016/j.ygyno.2012.01.050. Epub 2012 Feb 1. Gynecol Oncol. 2012. PMID: 22307064

10

Lipocalin 2 expression is associated with aggressive features of endometrial cancer.

Mannelqvist M, Stefansson IM, Wik E, Kusonmano K, Raeder MB, Øyan AM, Kalland KH, Moses MA, Salvesen HB, Akslen LA. Mannelqvist M, et al. Among authors: salvesen hb. BMC Cancer. 2012 May 6;12:169. doi: 10.1186/1471-2407-12-169. BMC Cancer. 2012. PMID: 22559235 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters